Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1997 Apr;71(4):3288–3292. doi: 10.1128/jvi.71.4.3288-3292.1997

Proteinase 3C-mediated processing of VP1-2A of two hepatitis A virus strains: in vivo evidence for cleavage at amino acid position 273/274 of VP1.

C Probst 1, M Jecht 1, V Gauss-Müller 1
PMCID: PMC191466  PMID: 9060697

Abstract

Two prominent features distinguish hepatitis A virus (HAV) from other members of the picornavirus family. A C-terminally prolonged precursor of the structural protein VP1 is incorporated into assembly intermediates (e.g., the provirion), and a single proteinase is contained within the HAV polyprotein. Using an in vivo expression system, we show that proteolytic liberation of VP1 from its precursors P1-2A and VP1-2A is catalyzed by the virus-encoded proteinase 3Cpro. Among the proposed cleavage sites within VP1-2A, the Glu/Ser pair found at VP1 amino acid position 273/274 of most HAV strains is efficiently processed, whereas proteolysis of the Val/Ser site of the attenuated HM175 strain is protracted. Two mutations within VP1-2A (Lys[297]Arg and Ser[330]Asn) had no effect on 3Cpro-mediated cleavage at this site. Additional sites in this region of VP1-2A can also be utilized as substrates by the proteinase, yet less efficiently, and might give rise to smaller and larger VP1 polypeptides also detected in HAV-infected cells.

Full Text

The Full Text of this article is available as a PDF (210.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. A., Ross B. C. Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles. J Virol. 1990 Nov;64(11):5284–5289. doi: 10.1128/jvi.64.11.5284-5289.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boege U., Scraba D. G. Mengo virus maturation is accompanied by C-terminal modification of capsid protein VP1. Virology. 1989 Feb;168(2):409–412. doi: 10.1016/0042-6822(89)90284-5. [DOI] [PubMed] [Google Scholar]
  3. Cho M. W., Ehrenfeld E. Rapid completion of the replication cycle of hepatitis A virus subsequent to reversal of guanidine inhibition. Virology. 1991 Feb;180(2):770–780. doi: 10.1016/0042-6822(91)90090-x. [DOI] [PubMed] [Google Scholar]
  4. Cohen J. I., Ticehurst J. R., Purcell R. H., Buckler-White A., Baroudy B. M. Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol. 1987 Jan;61(1):50–59. doi: 10.1128/jvi.61.1.50-59.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dotzauer A., Vallbracht A., Keil G. M. The proposed gene for VP1 of HAV encodes for a larger protein than that observed in HAV-infected cells and virions. Virology. 1995 Nov 10;213(2):671–675. doi: 10.1006/viro.1995.0040. [DOI] [PubMed] [Google Scholar]
  6. Dougherty W. G., Semler B. L. Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes. Microbiol Rev. 1993 Dec;57(4):781–822. doi: 10.1128/mr.57.4.781-822.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Elroy-Stein O., Fuerst T. R., Moss B. Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6126–6130. doi: 10.1073/pnas.86.16.6126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Emerson S. U., Lewis M., Govindarajan S., Shapiro M., Moskal T., Purcell R. H. cDNA clone of hepatitis A virus encoding a virulent virus: induction of viral hepatitis by direct nucleic acid transfection of marmosets. J Virol. 1992 Nov;66(11):6649–6654. doi: 10.1128/jvi.66.11.6649-6654.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gauss-Müller V., Lottspeich F., Deinhardt F. Characterization of hepatitis A virus structural proteins. Virology. 1986 Dec;155(2):732–736. doi: 10.1016/0042-6822(86)90234-5. [DOI] [PubMed] [Google Scholar]
  10. Gosert R., Cassinotti P., Siegl G., Weitz M. Identification of hepatitis A virus non-structural protein 2B and its release by the major virus protease 3C. J Gen Virol. 1996 Feb;77(Pt 2):247–255. doi: 10.1099/0022-1317-77-2-247. [DOI] [PubMed] [Google Scholar]
  11. Harmon S. A., Emerson S. U., Huang Y. K., Summers D. F., Ehrenfeld E. Hepatitis A viruses with deletions in the 2A gene are infectious in cultured cells and marmosets. J Virol. 1995 Sep;69(9):5576–5581. doi: 10.1128/jvi.69.9.5576-5581.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harmon S. A., Richards O. C., Summers D. F., Ehrenfeld E. The 5'-terminal nucleotides of hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity. J Virol. 1991 May;65(5):2757–2760. doi: 10.1128/jvi.65.5.2757-2760.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jewell D. A., Swietnicki W., Dunn B. M., Malcolm B. A. Hepatitis A virus 3C proteinase substrate specificity. Biochemistry. 1992 Sep 1;31(34):7862–7869. doi: 10.1021/bi00149a017. [DOI] [PubMed] [Google Scholar]
  14. Jia X. Y., Ehrenfeld E., Summers D. F. Proteolytic activity of hepatitis A virus 3C protein. J Virol. 1991 May;65(5):2595–2600. doi: 10.1128/jvi.65.5.2595-2600.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jia X. Y., Summers D. F., Ehrenfeld E. Primary cleavage of the HAV capsid protein precursor in the middle of the proposed 2A coding region. Virology. 1993 Mar;193(1):515–519. doi: 10.1006/viro.1993.1157. [DOI] [PubMed] [Google Scholar]
  16. Jürgensen D., Kusov Y. Y., Fäcke M., Kräusslich H. G., Gauss-Müller V. Cell-free translation and proteolytic processing of the hepatitis A virus polyprotein. J Gen Virol. 1993 Apr;74(Pt 4):677–683. doi: 10.1099/0022-1317-74-4-677. [DOI] [PubMed] [Google Scholar]
  17. Kusov YYu, Kazachkov Y. A., Dzagurov G. K., Khozinskaya G. A., Balayan M. S., Gauss-Müller V. Identification of precursors of structural proteins VP1 and VP2 of hepatitis A virus. J Med Virol. 1992 Jul;37(3):220–227. doi: 10.1002/jmv.1890370313. [DOI] [PubMed] [Google Scholar]
  18. Malcolm B. A., Chin S. M., Jewell D. A., Stratton-Thomas J. R., Thudium K. B., Ralston R., Rosenberg S. Expression and characterization of recombinant hepatitis A virus 3C proteinase. Biochemistry. 1992 Apr 7;31(13):3358–3363. doi: 10.1021/bi00128a008. [DOI] [PubMed] [Google Scholar]
  19. Martin A., Escriou N., Chao S. F., Girard M., Lemon S. M., Wychowski C. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts. Virology. 1995 Oct 20;213(1):213–222. doi: 10.1006/viro.1995.1561. [DOI] [PubMed] [Google Scholar]
  20. Palmenberg A. C. Proteolytic processing of picornaviral polyprotein. Annu Rev Microbiol. 1990;44:603–623. doi: 10.1146/annurev.mi.44.100190.003131. [DOI] [PubMed] [Google Scholar]
  21. Schultheiss T., Kusov Y. Y., Gauss-Müller V. Proteinase 3C of hepatitis A virus (HAV) cleaves the HAV polyprotein P2-P3 at all sites including VP1/2A and 2A/2B. Virology. 1994 Jan;198(1):275–281. doi: 10.1006/viro.1994.1030. [DOI] [PubMed] [Google Scholar]
  22. Schultheiss T., Sommergruber W., Kusov Y., Gauss-Müller V. Cleavage specificity of purified recombinant hepatitis A virus 3C proteinase on natural substrates. J Virol. 1995 Mar;69(3):1727–1733. doi: 10.1128/jvi.69.3.1727-1733.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tesar M., Jia X. Y., Summers D. F., Ehrenfeld E. Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4. Virology. 1993 Jun;194(2):616–626. doi: 10.1006/viro.1993.1301. [DOI] [PubMed] [Google Scholar]
  24. Wilk T., Mierswa H., Kräusslich H. G., Dunn J. J., Bosch V. Expression of biologically active HIV glycoproteins using a T7 RNA polymerase-based eucaryotic vector system. Virus Genes. 1992 Aug;6(3):229–246. doi: 10.1007/BF01702562. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES